These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24324051)

  • 41. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.
    Siciliano M; Mettimano M; Dondolini-Poli A; Ballarin S; Migneco A; Annese R; Fazzari L; Fedeli P; Montebelli MR; Zuppi C; Savi L
    Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients.
    Kelm M; Schäfer S; Mingers S; Heydthausen M; Vogt M; Motz W; Strauer BE
    J Hypertens; 1996 Nov; 14(11):1357-64. PubMed ID: 8934365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension].
    Cao Y; Zhao SP; Luo L
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):379-81. PubMed ID: 14653122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction.
    Matsui H; Shimosawa T; Uetake Y; Wang H; Ogura S; Kaneko T; Liu J; Ando K; Fujita T
    Hypertension; 2006 Aug; 48(2):225-31. PubMed ID: 16818802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Growth factors and cytokines (TGFBeta, bFGF and IGF-1) and cardiac left ventricular hypertrophy in hypertension].
    Kieć-Wilk B; Kawecka-Laszcz K; Stolarz K; Czech U; Dembińska-Kieć A
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S586-90. PubMed ID: 20527381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
    Salles GF; Deccache W; Cardoso CR
    J Hum Hypertens; 2005 Mar; 19(3):241-9. PubMed ID: 15660120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
    Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats.
    Monroy-Ruiz J; Sevilla MÁ; Carrón R; Montero MJ
    Pharmacol Res; 2011 Jan; 63(1):44-50. PubMed ID: 20868751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
    Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
    Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Would corrected QT dispersion predict left ventricular hypertrophy in hypertensive patients?
    Abdal-Barr MG; Safwat M; Nammas W
    Blood Press; 2012 Aug; 21(4):249-54. PubMed ID: 22428608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease.
    Zalba G; Beloqui O; San José G; Moreno MU; Fortuño A; Díez J
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1452-7. PubMed ID: 15860744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Left ventricular remodeling in association of arterial hypertension with diabetes mellitus type 2: correlation with gender and disease duration].
    Karpov RS; Koshel'skaia OA
    Ter Arkh; 2007; 79(1):32-8. PubMed ID: 17385461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertensive left ventricular hypertrophy: relation to beta-adrenergic receptor kinase-1 (betaARK1) in peripheral lymphocytes.
    Park SJ; Choi DJ; Kim CW
    J Hypertens; 2004 May; 22(5):1025-32. PubMed ID: 15097244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial.
    Yasuno S; Ueshima K; Oba K; Fujimoto A; Ogihara T; Saruta T; Nakao K
    J Hypertens; 2009 Aug; 27(8):1705-12. PubMed ID: 19412127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between electrocardiographic left ventricular hypertrophy with strain pattern and left ventricular structure and function.
    Ogah OS; Adebiyi AA; Oladapo OO; Aje A; Ojji DB; Adebayo AK; Salako BL; Falase AO
    Cardiology; 2006; 106(1):14-21. PubMed ID: 16601328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.
    Martin LC; Franco RJ; Gavras I; Matsubara BB; Garcia S; Caramori JT; Barretti BB; Balbi AL; Barsanti R; Padovani C; Gavras H
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1163-9. PubMed ID: 15607624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.